PP41 Gene transfer into joints by electroporation in vivo  by unknown
pyrophosphate (PPi). In light of numerous reports of anomalous 
regulation of PPi metabolism in patients with CPPDD, we ana- 
lyzed the ANK gene in a large French family. Direct sequencing of 
all exons of the gene revealed a heterozygous base substitution 
in exon 2 that changed a methionine to a threonine at amino acid 
position 48. No other amino acid changes were detected, and 
there was no evidence of any other sequence anomaly at 
intron/exon splice sites, nor in a region of the 5' UTR. The M~T 
sequence variant completely segregated with the disease pheno- 
type in the family. Furthermore, analysis of 200 alleles from con- 
trol subjects did not detect this missense mutation. 
Conclusions: Familial CPPDD is a genetic disorder that maps to 
chromosome 5p15.1 (locus name: CCAL2). Among the positional 
candidates in the disease interval is ANK, the human homolog of 
the mouse progressive ankylosis (ank) gene. In recessive ank/ank 
mice, loss of ank activity leads to a drop in extracellular PPi lev- 
els, resulting in unregulated apatite calcification in joints. 
Dominant mutations in ANK have recently been reported in 
Jackson-type cranial metaphyseal dysplasia (CMD) and it has 
been suggested that mutations in ANK in CMD patients result in 
decreased levels of extraceilular PPi, causing the increased bone 
density that is characteristic of CMD. We observed an M-T 
sequence variant in ANK in a French kindred with dominant 
CPPDD. It does not appear to significantly alter primary structure 
conformational parameters, nor does it affect the predicted sec- 
ondary structure of the protein. Nonetheless, position 48 and sur- 
rounding regions of the ANK protein are highly conserved in a 
variety of different vertebrates, including humans, frogs, and fish. 
The high degree of evolutionary conservation suggests that 
amino acid changes at this position are likely to have a deleteri- 
ous effect on ANK function. Studies to evaluate the impact of this 
missense mutation on the transport of PPi are underway. 
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Aim: Joint diseases are not lethal, therefore, absolute safety and 
high efficacy are required in gene therapies for joints. The pur- 
pose of this study was to develop an efficient non-viral gene 
delivery system for joint tissues using the electroporation i vivo. 
Materials and Methods: The expression vector pGEG.GL3 was 
composed of the luciferase gene under the control of the CAG 
promoter. The Epstein-Barr virus (EBV) oriP and EBV nuclear anti- 
gen (EBNA) 1 gene, which were the structures for the latent infec- 
tion by EBV, located downstream of another CAG promoter. The 
conventional vector, pG.GL.3, carries the luciferase gene driven 
by the CAG promoter but not EBNA 1 gene nor oriR Fifty micro- 
gram of the plasmids were injected into the knee joints of Dark 
Agouti (DA) rats, and different voltages of electric pulses (25- 
500V) were applied transcutaneously. Three days after the trans- 
fection, the synovium was collected and the luciferase activity 
was measured. 
Results: Marked enhancement of luciferase expression was 
observed when an electric pulse was applied after intra-articular 
DNA injection. The highest luciferase activity was achieved in the 
joints pulsed at 200V. The expression level of the electrotrans- 
ferred DNA was much higher than that of naked DNA delivered 
without electric pulsation (up to 600-fold). Up to 8-fold higher 
luciferase activity was demonstrated with pGEG.GL3 than with 
pG.GL.3. 
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Conclusions: In the present study, quite high transfection effi- 
ciency into synovium was achieved by intra-articular injection of 
naked plasmid DNA followed by an electric pulsation. The EBV- 
based plasmid vector augmented the transfection efficiency. The 
results demonstrated that the electroporation i vivo using EBV- 
based plasmid vector could provide a useful and safe method for 
the direct intra-articular gene delivery for joint diseases. 
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Aim: The aim of this study was to establish two collagen mutant 
mouse lines as separate animal models for the study of early- 
onset osteoarthritis (CA) in the human chondrodysplasias, e.g., 
Stickler syndrome. Experiments were designed to determine the 
extent of the degenerative changes in articular cartilage and to 
establish the age of onset of the disease. 
Methods: With wild-type (+/+) littermates erving as controls, 
knee-joints from heterozygous mice carrying the semidominant 
Col2al mutation Disproportionate micrometia (Dram) or the 
recessive Colllal mutation chondrodysplasia (cho) were exam- 
ined with histological (H&E), histochemical (safranin O), ultra- 
structural, and immunofluorescence (col2-3/4m antibody for 
detecting degraded type II collagen) techniques. 
Results: In both mutants, degenerative changes were observed 
in articular cartilage several months prior to being observed in the 
control group. Morphological changes included alterations in 
organization and number of chondrocytes, staining of the matrix, 
and extent of fibrillogenesis. These changes were typically 
observed in the superficial zone but extended into the transition- 
al zone. Likewise, degraded collagen was detected primarily in 
the superficial and transitional zones in both mutants. Overall, 
these changes were more pronounced in mice carrying the Dram 
gene compared with mice carrying the cho gene. 
Conclusions: These results support the hypothesis that mice 
carrying the Dmm and cho genes develop premature CA, and 
thus provide the opportunity of studying chondrodysplasia-asso- 
ciated degeneration of articular cartilage as early as 6 months in 
two different murine models. Our observations uggest that the 
dominant-negative effect of the Dram gene predisposes articular 
cartilage to more severe and earlier onset CA than does the 
apparent hap]oinsufficiency caused by the recessive cho muta- 
tion. Study of these two mutations in mice provides the opportu- 
nity of elucidating the mechanism and of providing early diagno- 
sis and therapy for chondrodysplasia-associated CA
